Vultaggio Vincent's Form 4 filing
Zentalis Pharmaceuticals, Inc. (ZNTL) · filed Feb 4, 2026
- Accession no.
- 0002018766-26-000004
- Filed
- Feb 4, 2026
- Trade date
- Feb 2-3, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $7.88K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vultaggio VincentCIK 0002018766 | Officer (PAO and PFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | SSaleDisposed | −2,540 | $2.55 | −$6,477 | 187,286 | Direct | |
| Feb 3, 2026 | Common Stock | SSaleDisposed | −556 | $2.52 | −$1,401.12 | 186,730 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.